Nuvation Bio Inc Class A (NUVB)
SG&A Expense Growth
11.18%
Quarterly · Period ending:
NUVB SG&A Expense Growth
Latest reported11.18%period ending
Latest reported11.18%period ending
NUVB Quarterly SG&A Growth (QoQ) (0.00% → 11.18%)
Latest values, visible window
High-resolution chart · PNG
NUVB sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 11.1775% | |
| -5.0017% | |
| 7.9419% | |
| -2.9233% | |
| 8.7334% | |
| 35.4082% | |
| 33.4797% | |
| 21.2058% | |
| 119.6004% | |
| 34.2518% | |
| -29.5449% | |
| 3.1428% | |
| -2.4955% | |
| 3.6174% | |
| -7.2103% | |
| -10.1028% | |
| 19.8982% | |
| -1.893% | |
| 34.1859% | |
| -11.4219% | |
| 38.9794% | |
| 3.9034% | |
| 51.8328% | |
| 74.5813% | |
| -13.1429% | |
| 5.7111% | |
| 26.5462% | |
| -22.9038% | |
| 0% | |
| 0% |